Patient discussions
An initial official consultation for AR should include:
Information on allergen avoidance (only if allergy testing has been performed - there is no value in discussing avoidance of 'typical' allergens without confirming that they are relevant to the patient)
An action plan detailing various aspects of the chosen pharmacological agent(s)
Expected clinical outcomes.
Details on medications should include:
Appropriate dosing frequency and technique (including teaching on proper administration of nasal sprays)
Whether treatments should be used on a schedule or as needed
Expected time to clinical improvement
Possible adverse effects (e.g., sedation with first-generation antihistamines).
Finally, plans for appropriate follow-up should be made. The patient should be re-assessed after a trial of monotherapy with an intranasal corticosteroid or oral antihistamine (ideally within 5-7 days).[3]
Use of this content is subject to our disclaimer